Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Axsome Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner | Restricted Stock Units | 47.9K | $3.6M | $75.18 | Feb 27, 2024 | Direct |
Axsome Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner | Employee Stock Option (Right to Buy) | 87.2K | Feb 27, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AXSM | Axsome Therapeutics, Inc. | Feb 27, 2024 | 2 | $0 | 4 | Feb 29, 2024 | CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner |
AXSM | Axsome Therapeutics, Inc. | Mar 2, 2023 | 2 | $0 | 4 | Mar 6, 2023 | CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner |
AXSM | Axsome Therapeutics, Inc. | Mar 4, 2022 | 2 | $0 | 4 | Mar 8, 2022 | CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner |